Real-world data and artificial intelligence (AI) are poised to revolutionize drug development by optimizing clinical trials and regulatory approvals, if data quality and patient privacy challenges are addressed.
Mike Munsell, PhD
Advertisement
Articles by Mike Munsell, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Clinical Data Support Use of Low-Carbon Version of Albuterol Metered Dose Inhaler for Asthma
2
States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments
3
FDA Expands Approval of Sotatercept-Csrk for Pulmonary Arterial Hypertension
4
Expert Insights on Key Data from IMS 2025
5
